Rapid dose titration of quetiapine for the treatment of acute schizophrenia and acute mania: A case series

Journal of Psychopharmacology

Volumn 20, Issue 1, 2006, Pages 119-124

  Pajonk, Frank Gerald B ^a   Schwertner, Anne K ^a   Seelig, Marko Alexander ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Acute symptoms; High dose; Mania; Quetiapine; Schizophrenia; Tolerability

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROTHIXENE; DIAZEPAM; HALOPERIDOL; HYPNOTIC AGENT; LAMOTRIGINE; LITHIUM; LORAZEPAM; NEUROLEPTIC AGENT; NITRAZEPAM; PIPAMPERONE; PROTHIPENDYL; QUETIAPINE; VALPROIC ACID; ZUCLOPENTHIXOL ACETATE; DIBENZOTHIAZEPINE DERIVATIVE;

ADULT; ARTICLE; BEHAVIOR DISORDER; BIPOLAR MANIA; CLINICAL ARTICLE; CONFUSION; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; GAIT DISORDER; HUMAN; HYPOTENSION; MALE; MANIA; NERVOUSNESS; PRIORITY JOURNAL; SCHIZOPHRENIA; SEDATION; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; SPEECH DISORDER; TACHYCARDIA; THOUGHT DISORDER; TITRIMETRY; ACUTE DISEASE; ADOLESCENT; BIPOLAR DISORDER; CASE REPORT; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY;

ACUTE DISEASE; ADOLESCENT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DIBENZOTHIAZEPINES; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 33645233689     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881105056665     Document Type: Article

References (24)

1. Arango C, Bobes J (2004) Managing acute exacerbations of schizophrenia: focus on quetiapine. Curr Med Res Opin 20: 619-626
2. Arvanitis L A, Miller B G, the Seroquel Trial 13 Study Group (1997) Multiple fixed doses of 'Seroquel' (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. Biol Psychiatry 42: 233-246
3. Ashim S, Warrington S, Anderson I M (2004) Management of diabetes mellitus occurring during treatment with olanzapine: report of six cases and clinical implications. J Psychopharmacol 18: 128-132
4. Bobes J, Garcia-Portilla M P, Saiz P A, Bascaran M-T, Bousono M, Arango C (2002) High degree of tolerability for monotherapy with high doses of quetiapine: a case report. J Clin Psychiatry 63: 1048-1049
5. Bowden C L, Grunze H, Mullen J, Brecher M, Paulsson B, Vågerö M, Svensson K (2004) An international, double-blind, randomized, placebo-controlled study of the efficacy and safety of quetiapine as monotherapy for mania associated with bipolar disorder. J Clin Psychiatry 66: 111-121
6. Brecher M, Rak I W, Melvin K, Jones A M (2000) The long-term effect of quetiapine (Seroquel™) monotherapy on weight in patients with schizophrenia. Int J Psychiatry Clin Pract 4: 287-291
7. Bressan R A, Jones H M, Pilowsky L S (2004) Atypical antipsychotic drugs and tardive dyskinesia: relevance of D2 receptor affinity. J Psychopharmacol 18: 124-127
8. Calabrese J, Vieta E, Mullen J, Brecher M, Paulsson B, Jones M (2004) Quetiapine monotherapy for mania associated with bipolar disorder. Analysis of two international, double blind, randomised, placebo-controlled studies. Acta Psychiatr Scand (Submitted)
9. Copolov D L, Link C G G, Kowalcyk B (2000) A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, 'Seroquel') and haloperidol in schizophrenia. Psychol Med 30: 95-105
10. Davis J M, Chen N (2004) Dose response and dose equivalence of antipsychotics. J Clin Psychopharmacol 24: 192-208
11. Emsley R A, Buckley P, Jones M, Greenwood M R (2003) Differential effect of quetiapine on depressive symptoms in patients with partially responsive schizophrenia. J Psychopharmacol 17: 210-215
12. Ganesan S, Levy M, Bilsker D (2003) Effectiveness of quetiapine treatment of aggressive psychosis in the emergency psychiatric setting: a naturalistic pilot study. Poster NR412 presented at the American Psychiatric Association 156th Annual Meeting, San Francisco, CA, USA, 17-22 May
13. Goldstein J M, Zhong K X (2004) Tolerance to somnolence with quetiapine: preclinical mechanisms and clinical evidence. Poster 322 presented at the 157th Annual Meeting of the American Psychiatric Association, New York, USA, 1-6 May
14. Hellewell J S E, Kalali A H, Langham S J, McKellar J, Awad A G (1999) Patient satisfaction and acceptability of long-term treatment with quetiapine. Int J Psychiatry Clin Pract 3: 105-113
15. Kasper S, Müller-Spahn F (2000) Review of quetiapine and its clinical applications in schizophrenia. Expert Opin Pharmacother 1: 783-801
16. Keks N, Tonso M, Tabone K, Thomas R, Tune P, D'Souza R, McHugh M (2003) Experience with atypical antipsychotics in an acute inpatient unit. International Congress on Schizophrenia Research, Colorado Springs, CO, USA, 29 March-2 April
17. Kinon B J, Ahl J, Stauffer V L, Hill A L, Buckley P F (2004) Dose response and atypical antipsychotics in schizophrenia. CNS Drugs 18: 597-616
18. Mishra A, Moore P B, Hobbs R (2004) Does quetiapine have mood altering properties? J Psychopharmacol 18: 281-284
19. Mullen J, Jibson M D, Sweitzer D, for the QUEST Study Group (2001) A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the Quetiapine Experience with Safety and Tolerability (QUEST) study. Clin Ther 23: 1839-1854
20. Nagy J (2003) Effectiveness of quetiapine up to 1600 mg/day: short-term results with 14-month follow-up. Eur Neuropsychopharmacol 13 (Suppl. 4): S340
21. Sachs G, Chengappa K N R, Suppes T, Mullen J, Brecher M, Devine N A, Sweitzer D (2004) Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar Disord 6: 213-223
22. Smith M A, McCoy R N, Hamer J, Brecher M, Goldstein J M (2003) Optimal titration for quetiapine: a pilot study. Poster NR568 presented at the 156th Annual Meeting of the American Psychiatric Association, San Francisco, CA, USA, 17-22 May
23. Tandon R, Jibson M D (2003) Efficacy of newer generation antipsychotics in the treatment of schizophrenia. Psychoneuroendocrinology 28 (Suppl. 1): 9-26
24. Velligan D I, Newcomer J, Pultz J, Csernansky J, Hoff A L, Mahurin R, Miller A L (2002) Does cognitive function improve with quetiapine in comparison to haloperidol? Schizophr Res 53: 239-248